| Product NDC: | 66336-916 | 
| Proprietary Name: | Spironolactone | 
| Non Proprietary Name: | spironolactone | 
| Active Ingredient(s): | 25 mg/1 & nbsp; spironolactone | 
| Administration Route(s): | ORAL | 
| Dosage Form(s): | TABLET, FILM COATED | 
| Coding System: | National Drug Codes(NDC) | 
| Product NDC: | 66336-916 | 
| Labeler Name: | Dispensing Solutions, Inc. | 
| Product Type: | HUMAN PRESCRIPTION DRUG | 
| FDA Application Number: | ANDA040750 | 
| Marketing Category: | ANDA | 
| Start Marketing Date: | 20060829 | 
| Package NDC: | 66336-916-60 | 
| Package Description: | 60 TABLET, FILM COATED in 1 BOTTLE (66336-916-60) | 
| NDC Code | 66336-916-60 | 
| Proprietary Name | Spironolactone | 
| Package Description | 60 TABLET, FILM COATED in 1 BOTTLE (66336-916-60) | 
| Product NDC | 66336-916 | 
| Product Type Name | HUMAN PRESCRIPTION DRUG | 
| Non Proprietary Name | spironolactone | 
| Dosage Form Name | TABLET, FILM COATED | 
| Route Name | ORAL | 
| Start Marketing Date | 20060829 | 
| Marketing Category Name | ANDA | 
| Labeler Name | Dispensing Solutions, Inc. | 
| Substance Name | SPIRONOLACTONE | 
| Strength Number | 25 | 
| Strength Unit | mg/1 | 
| Pharmaceutical Classes | Aldosterone Antagonist [EPC],Aldosterone Antagonists [MoA] |